G-Quadruplexes Modulate TDP-43 Condensation and Toxicity

Protein condensation and aggregation are central features of several neurodegenerative diseases, but the nucleic-acid factors that shape these processes remain incompletely defined. In the 2025 Structure short article, Oldani and colleagues investigate whether G-quadruplexes, or G4s, directly regulate the behavior of trans-active response DNA-binding protein 43 kDa, usually called TDP-43. Their experiments connect G4 structure, TDP-43 condensation, intracellular localization, and cytotoxicity across in vitro systems, yeast, HEK293T cells, and motor-neuron-like NSC-34 cells.

The work is important because it moves beyond describing G4s as binding partners. It tests whether changing the G4 population can change the physical state and biological consequences of TDP-43. The findings, reported in the reference study by Oldani et al., provide a mechanistic rationale for investigating RNA secondary structures in amyotrophic lateral sclerosis and related protein-misfolding disorders.

Study Background and Research Question

TDP-43 is an RNA-binding protein involved in multiple stages of RNA metabolism and transcript regulation. Although it is primarily nuclear, TDP-43 also occupies the cytoplasm in healthy cells. In ALS and frontotemporal lobar degeneration, abnormal TDP-43 inclusions are frequently observed. Aggregation of wild-type TDP-43 is particularly relevant to sporadic ALS, which represents most ALS cases, yet the molecular events that initiate or sustain this aggregation are not fully resolved.

Several observations suggested that RNA may act as a chaperone or regulator of TDP-43. For example, the long non-coding RNA NEAT1 and lariat introns have been associated with reduced TDP-43 toxicity in experimental systems, while short TDP-43-binding oligonucleotides can lessen neurotoxic aggregation. TDP-43 also binds G4s, which are four-stranded nucleic-acid structures formed when guanine-rich sequences assemble into stacked tetrads stabilized by cations. RNA G4s are reported to form preferentially under cellular stress, a condition relevant to neurodegenerative disease.

Against this background, the central question was whether G4s merely bind TDP-43 or actively modulate its aggregation, condensation, distribution, and toxicity. The study also asks whether G4-binding small molecules can reproduce useful effects by increasing G4 stability in cells.

Key Innovation from the Reference Study

The main innovation is the integration of structural biology with protein-condensate biology. Rather than measuring only whether TDP-43 binds a G4 sequence, the authors examine how G4s alter TDP-43 behavior in different physical and biological contexts. This distinction matters because a visible aggregate is not necessarily equivalent to a toxic species. Changes in condensate abundance, composition, mobility, localization, or persistence may have different effects on cell survival.

A second strength is the use of complementary perturbations. Defined G4 structures were examined in biochemical experiments, while cellular studies used G4 exposure or G4-binding small molecules under stress conditions. The authors then compared TDP-43 accumulation, condensation, G4 co-localization, and toxicity rather than relying on a single endpoint. According to the published report, this cross-model strategy indicates that G4s can buffer or redirect TDP-43-associated damage, depending on the experimental context.

Methods and Experimental Design Insights

The study begins with an in vitro aggregation system containing eGFP-tagged TDP-43. DNA G4s were used in this initial biochemical analysis to determine whether a preformed quadruplex can directly influence TDP-43 aggregation. This design separates a direct effect of nucleic-acid structure from cellular variables such as transcription, proteostasis, stress signaling, or membrane transport.

The cellular experiments extend the analysis to three distinct models. In Saccharomyces cerevisiae expressing TDP-43, treatment with G4s was used to examine the relationship between TDP-43 accumulation and cell tolerance. HEK293T cells expressing TDP-43 were exposed to proteasomal or oxidative stress, allowing the investigators to test whether stabilizing G4s changes stress-induced TDP-43 condensation. Finally, NSC-34 motor-neuron-like cells expressing exogenous TDP-43 were used to assess G4 localization near TDP-43 condensates and the consequences of G4-binding small molecules for cell toxicity.

This arrangement provides a useful experimental logic. The biochemical arm asks whether G4s can act directly. The yeast arm supplies a tractable toxicity and survival model. HEK293T cells support analysis of stress-responsive condensation and G4 stability, while NSC-34 cells provide greater relevance to motor-neuron biology. No single model establishes disease causality, but convergence across models strengthens the argument that G4-dependent regulation is biologically meaningful.

Protocol Parameters

• In vitro comparison: Compare TDP-43 aggregation in the presence and absence of defined G4-forming oligonucleotides while keeping sequence, ionic composition, protein concentration, and incubation history consistent; this reflects the reference study’s direct-perturbation strategy.
• Cellular model selection: Treat yeast, HEK293T, and NSC-34 experiments as complementary rather than interchangeable, because they address survival, stress-induced condensation, and motor-neuron-like toxicity, respectively.
• Stress conditions: In follow-up work, distinguish baseline conditions from proteasomal and oxidative stress rather than pooling all stress treatments into one category.
• Readout integration: Measure TDP-43 abundance or distribution together with condensate formation, G4 localization or stability, and cell survival; accumulation alone should not be interpreted as proof of increased toxicity.

Core Findings and Why They Matter

First, G4s directly modulated eGFP-TDP-43 aggregation in vitro. This result establishes that the effect does not require a complete cellular stress response. It also supports the idea that nucleic-acid secondary structure can influence the assembly pathway of an aggregation-prone RNA-binding protein.

Second, G4 treatment in yeast increased TDP-43 accumulation before cell death while improving cellular tolerance to TDP-43. This apparently counterintuitive result is one of the study’s most informative observations. It suggests that more visible or measurable TDP-43 accumulation does not necessarily indicate a more damaging state. G4s may redistribute TDP-43 into assemblies that are less disruptive, or they may alter the timing of toxic events. The data therefore argue for separating aggregate quantity from aggregate quality and cellular outcome.

Third, in HEK293T cells, G4-binding small molecules increased G4 stability, stabilized TDP-43, and reduced TDP-43 condensation induced by proteasomal or oxidative stress. The finding links chemical stabilization of a nucleic-acid structure to a change in protein behavior inside cells. It does not show that all G4 ligands will have the same activity, but it supports chemical interrogation of G4-dependent TDP-43 regulation.

Fourth, in NSC-34 cells, G4s co-localized with TDP-43 condensates under stress, and G4-binding small molecules reduced TDP-43-mediated toxicity. This observation places G4s at the site of disease-relevant protein condensation rather than treating them as distant upstream regulators. Taken together, the results suggest that the intracellular G4 population can influence where TDP-43 accumulates, how it condenses, and whether that state is harmful.

The broader implication for telomere biology research is not direct disease translation but conceptual expansion: G-quadruplexes should be considered regulatory nucleic-acid structures in multiple cellular settings. For ALS research, the immediate value is the identification of a potentially tractable structural variable that can be measured and perturbed.

Comparison with Existing Internal Articles

The internal article G-Quadruplexes Modulate TDP-43 Aggregation and Toxicity in ALS Models provides a concise overview of the same research direction, emphasizing the relationship between RNA G4s, TDP-43 aggregation, and toxicity. The present analysis adds methodological interpretation: the study’s significance comes from its progression from direct biochemical effects to stress-dependent cellular phenotypes, and from its distinction between TDP-43 accumulation and toxicity.

That relationship is useful for readers comparing a high-level study summary with the primary evidence. The internal article should be treated as contextual reading, whereas the Structure publication remains the appropriate source for experimental details and the authors’ reported conclusions.

Limitations and Transferability

Several limitations affect how broadly the findings should be interpreted. The study uses DNA G4s in the initial in vitro aggregation experiments but focuses on RNA G4s as the relevant cellular structures. DNA and RNA quadruplexes can differ in topology, sequence behavior, folding conditions, and interactions with proteins or ligands. Therefore, a result obtained with a DNA G4 is not automatically equivalent to an effect on an endogenous RNA G4.

The cellular models also rely on experimentally expressed TDP-43 rather than fully reproducing the heterogeneous molecular environment of patient-derived motor neurons or ALS tissue. Overexpression can increase condensation and stress sensitivity, making it useful for mechanism discovery but potentially different from endogenous disease progression. The absence of in vivo or clinical validation means that the work supports a research hypothesis, not a therapeutic conclusion.

G4-binding small molecules introduce an additional interpretive issue. Reduced toxicity after ligand treatment is consistent with G4-mediated regulation, but it does not by itself prove that the compound acts only through the intended G4 structure. Cellular uptake, ligand distribution, stress responses, and other nucleic-acid interactions may contribute. Future studies should therefore pair ligand experiments with direct structural measurements, endogenous TDP-43 systems, time-resolved imaging, and controls that distinguish RNA-G4 effects from nonspecific changes in proteostasis.

Finally, the study shows that G4-dependent TDP-43 accumulation can accompany increased tolerance in yeast. This cautions against using aggregate counts as a universal efficacy endpoint. A transferable workflow should evaluate molecular distribution, condensate state, timing, and cell function together.

Research Support Resources

For related G-quadruplex structure-probing workflows, researchers can use Pyridostatin (SKU A3742), a synthetic small molecule described as a stabilizer of G-quadruplex DNA structures. Pyridostatin TFA is the commonly handled TFA salt form and may support DNA secondary structure research and telomere biology research. These applications are adjacent to, but distinct from, the RNA-G4/TDP-43 experiments in the reference study; they should not be interpreted as evidence that the compound is an established TDP-43 treatment, a validated cancer cell growth inhibitor, or a finished tool for anticancer drug development. Experimental users should validate sequence, structure, cell type, dosing, and stress conditions in their own system.